Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (1) , 55-60
- https://doi.org/10.1016/0277-5379(90)90257-t
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Localization of a nonintercalative DNA binding antitumour drug in mitochondria: Relationship to multidrug resistanceEuropean Journal of Cancer and Clinical Oncology, 1989
- The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoproteinNature, 1989
- Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparumCell, 1989
- Reversal of Chloroquine Resistance in Malaria Parasite Plasmodium falciparum by DesipramineScience, 1988
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Verapamil modulates mutagenicity of antitumour acridines in bacteria and yeastBiochemical Pharmacology, 1986
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinomaBritish Journal of Cancer, 1986
- Verapamil Reversal of Clinical Doxorubicin Resistance in Human Cancer A Wilshire Oncology Medical Group Pilot Phase I-II StudyAmerican Journal of Clinical Oncology, 1986